A framework for stimulating economic investments to prevent emerging diseases.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Ethical health security in the age of antimicrobial resistance.BMJ global health · 2022
   Article
2. Implementing One Health approaches to confront emerging and re-emerging zoonotic disease threats: lessons from PREDICT.One health outlook · 2020
   Review
3. New frontiers in applied veterinary point-of-capture diagnostics: Toward early detection and control of zoonotic influenza.Influenza and other respiratory viruses · 2019
   Article
4. The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases - focus on populations underserved.Infectious diseases of poverty · 2019
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as